Building Service Infrastructure for “Made-To-Order” Therapies
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization.
Kostja Paschalidis</a> is the Co-Founder, Systems & Logistics of <a href=https://medcitynews.com/author/kpaschalidis/"https://www.firm.inc/">Firm, a consultancy specializing in designing the services and building the capabilities that enable pharmaceutical companies to deliver advanced therapies at scale. He specializes in operational strategy, process optimization, and logistics innovation within the biotech and healthcare industries. Kostja merges technical insight with strategic planning, re-engineering systems to align with evolving medical advancements to help organizations refine their approaches to developing and delivering transformative treatments." />
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization.